Iran vs Tajikistan: The number of people with susceptibility test result for rifampicin
Iran
1,828
in 2021
Tajikistan
1,862
in 2021
Iran rank
51st
Tajikistan rank
50th
The number of people with susceptibility test result for rifampicin over time
- Iran
- Tajikistan
How they compare
Tajikistan currently reports 1,862 against 1,828 in Iran, a difference of 34.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Iran ahead.
Iran ranks 51st and Tajikistan ranks 50th of 155 countries.
Across the 2 decades both report, Iran averaged higher in 1 and Tajikistan in 1.
Head to head by decade
| Decade | Iran | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3,008 | 2,412 | 596 | Iran |
| 2020s | 1,608 | 1,772 | 165 | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Iran or Tajikistan?
- Tajikistan, at 1,862 against 1,828 in Iran as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Iran and Tajikistan?
- 34, with Tajikistan ahead.
- How many years of comparable data are there for Iran and Tajikistan?
- 5 years are reported by both, from 2017 to 2021.
- How do Iran and Tajikistan rank globally for the number of people with susceptibility test result for rifampicin?
- Iran ranks 51st and Tajikistan ranks 50th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.